Cantharidin Causes Hepatotoxicity by Disrupting GSH‐Mediated Redox Homeostasis
Journal of Applied Toxicology · 23.08.2026
DOI: 10.1002/jat.70396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 23.08.2026. Verfasst von Hong Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Devel…. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Cantharidin (CTD) possesses potent anticancer activity, whereas its prominent hepatotoxicity severely limits its clinical application. Because the detailed molecular mechanisms responsible for CTD‐triggered hepatotoxicity have not been fully elucidated, additional investigations are necessary to uncover its toxicological pathways. This study investigated the mechanism of CTD‐triggered hepatotoxicity and the protective effects of exogenous glutathione (GSH) supplementation. In vitro results showed that CTD reduced the GSH/glutathione disulfide (GSSG) ratio and the activities of catalase (CAT) and glutathione peroxidase (GPX) in hepatocytes, induced a compensatory upregulation of superoxide dismutase (SOD), and promoted malondialdehyde (MDA) accumulation. Additionally, CTD downregulated glutamate‐cysteine ligase modifier subunit (GCLM) expression, decreased mitochondrial membrane potential (MMP), suppressed B‐cell lymphoma 2 (Bcl‐2) expression, and upregulated Bcl‐2‐associated X protein (Bax), cysteine‐dependent aspartate‐directed protease (caspase‐9), downstream caspase‐3, and cytochrome c (Cyt c) levels, thereby triggering hepatocyte apoptosis, with no significant changes in cellular cysteine (Cys) content and glutamate‐cysteine ligase catalytic subunit (GCLC) expression. In vivo experiments verified that CTD markedly decreased hepatic GSH and Cys levels and downregulated GCLC expression, whereas GCLM expression and hepatic Cyt c levels showed only a slight upward trend without statistical significance. Glutathione ethyl ester (GSH‐OEt) pretreatment in vitro and GSH intervention in vivo effectively prevented CTD‐caused oxidative damage. Collectively, CTD induces divergent expression patterns of glutamate‐cysteine ligase (GCL) subunits in vitro and in vivo, disrupts GSH metabolic homeostasis, and provokes oxidative stress and mitochondrial dysfunction, ultimately leading to hepatocellular injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Educati…
- School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
- Colleges of Material and Chemistry Engineering, Tongren University, Tongren, China.
- School of Pharmacy, Guizhou Medical University, Guiyang, China.
- Natural Products Research Center of Guizhou Province, Guiyang, China.
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
ORCID-Profile: Qing Rao, Ting Liu, Zhanhui Feng, Ying Peng, Jiang Zheng
Zitieren
APA
Tang, H., Rao, Q., Liu, T., Hu, Z., Feng, Z., Chen, Y., He, Y., Cui, D., Li, X., Zhang, Q., Peng, Y., Li, W., & Zheng, J. (2026). Cantharidin Causes Hepatotoxicity by Disrupting GSH‐Mediated Redox Homeostasis. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70396
Vancouver
Tang H, Rao Q, Liu T, Hu Z, Feng Z, Chen Y, et al. Cantharidin Causes Hepatotoxicity by Disrupting GSH‐Mediated Redox Homeostasis. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70396
BibTeX
@article{Tang2026,
author = {Tang, Hong and Rao, Qing and Liu, Ting and Hu, Zixia and Feng, Zhanhui and Chen, Yu and He, Yan and Cui, Dongbing and Li, Ximei and Zhang, Qing and Peng, Ying and Li, Weiwei and Zheng, Jiang},
title = {Cantharidin Causes Hepatotoxicity by Disrupting GSH‐Mediated Redox Homeostasis},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70396}
}
EUVIMED